Ilya Kister, MD, on the Risks of Stopping MS Disease-Modifying Therapies

Ilya Kister, MD, from NYU Langone Health, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying therapies.

Ilya Kister, MD, is an associate professor in the Department of Neurology at NYU Langone Health in New York City.

Submit Feedback